Our study observed a direct correlation between Ki 67 cell proliferation and intratumoral CD34 expression, but no correlation between Ki67 expression and Gleason scores, as observed in the study [81], which concluded that this nuclear biomarker could be a prognostic factor for prostate cancer. The gene discussed is MKI67; the disease is prostate cancer.